Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,281 | -26,960 | -19,469 | -11,457 | -4,786 |
| Depreciation Amortization | 3 | 8 | 6 | 4 | 2 |
| Accounts payable and accrued liabilities | -1,521 | 1,248 | -64 | 335 | -121 |
| Other Working Capital | -2,317 | -599 | -2,020 | -2,952 | -1,900 |
| Other Operating Activity | 3,094 | 5,543 | 5,310 | 3,243 | 1,927 |
| Operating Cash Flow | $-7,022 | $-20,760 | $-16,237 | $-10,827 | $-4,878 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -27 | -19 | -13 | -13 |
| Purchase Of Investment | N/A | -4,700 | -2,700 | N/A | N/A |
| Investing Cash Flow | $N/A | $-4,727 | $-2,719 | $-13 | $-13 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | -54 | N/A | N/A |
| Beginning Cash Position | 111,000 | 136,487 | 136,487 | 136,487 | 136,487 |
| End Cash Position | 103,978 | 111,000 | 117,477 | 125,647 | 131,596 |
| Net Cash Flow | $-7,022 | $-25,487 | $-19,010 | $-10,840 | $-4,891 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,022 | -20,760 | -16,237 | -10,827 | -4,878 |
| Capital Expenditure | N/A | -27 | -19 | -13 | -13 |
| Free Cash Flow | -7,022 | -20,787 | -16,256 | -10,840 | -4,891 |